Czech Republic,
November 2012
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world. Located at the beating heart of Europe, boasting a highly-talented yet low-cost workforce, and with a rapidly evolving regulatory framework, the Czech Republic is fast establishing itself as a significant country globally for pharmaceuticals and healthcare.
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Czech healthcare and pharma sectors.
This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world. Located at the beating heart of Europe, boasting a highly-talented yet low-cost workforce, and with a rapidly evolving regulatory framework, the Czech Republic is fast establishing itself as a significant country globally for pharmaceuticals and healthcare.
The report features in-depth exclusive interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts and figures on the Czech healthcare and pharma sectors.
